Literature in Oncology: Lung
Møller DS, Khalil AA, Knap MM, Hoffmann L.
Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis.
Radiother Oncol. 2014 Mar;110(3):517-22.
Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.
Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
Acad Radiol. 2014 Jan;21(1):11-20
Sim YT, Goh YG, Dempsey MF, Han S, Poon FW.
PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.
Lung. 2013 Dec;191(6):625-32.
Schaefer A, Kim YJ, Kremp S, Mai S, Fleckenstein J, Bohnenberger H, Schäfers HJ, Kuhnigk JM, Bohle RM, Rübe C, Kirsch CM, Grgic A.
PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings.
Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1233-44.
Hatt M, Cheze-le Rest C, van Baardwijk A, Lambin P, Pradier O, Visvikis D.
Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation.
J Nucl Med. 2011 Nov;52(11):1690-7.
Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ.
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
Eur J Nucl Med Mol Imaging. 2011 May;38(5):810-21.
Pommier P, Touboul E, Chabaud S, Dussart S, Le Pechoux C, Giammarile F, Carrie C.
Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study.
AJR Am J Roentgenol. 2010 Aug;195(2):350-5.
Stahel RA, Weder W, Lievens Y, Felip E; ESMO Guidelines Working Group.
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2010 May;21 Suppl 5:v126-8.
Chee KG, Nguyen DV, Brown M, Gandara DR, Wun T, Lara PN Jr.
Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited.
Arch Intern Med. 2008 Jul 28;168(14):1541-9.
Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, Langen HJ, Bares R.
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.
Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):463-71.
Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL.
Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):709-19.
Song Y, Chan M, Burman C, Cann D.
Inter-modality variation in gross tumor volume delineation in 18FDG-PET guided IMRT treatment planning for lung cancer.
Conf Proc IEEE Eng Med Biol Soc. 2006;1:3803-6.
Schillaci O.
Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
Semin Nucl Med. 2006 Oct;36(4):275-85.